Michael William Pennington
Direttore Tecnico/Scientifico/R&S presso Ambio Pharmaceuticals
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Stephen John Kiel | M | 71 |
AmbioPharm, Inc. (South Carolina)
 AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 anni |
| Jun Cai Bai | M | 61 |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 17 anni |
| Timothy Nieters | M | 52 |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 9 anni |
| Peter Joe Pitts | M | 65 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 anni |
| Chong Sun Chung | M | 48 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 anni |
| Craig Marshall Lea | M | 71 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 anni |
| Brian Gregg | M | - |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | 1 anni |
| Ling Yang | F | 44 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 anni |
| Xiao Bo Lu | M | 51 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 anni |
| Shing Cheung Wong | M | 37 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | - |
| Hao Zhang | M | 42 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Alan Levine | M | 56 |
University of Florida
| 7 anni |
| Brent D. Barringer | M | 65 |
The University of North Carolina at Chapel Hill
| 7 anni |
| Scott P. Distasio | M | - |
University of Florida
| 8 anni |
| Satendra S. Chauhan | M | - |
Peptides International LLC
 Peptides International LLC BiotechnologyHealth Technology Peptides International, Inc. manufactures and distributes biochemical products. It engages in research and development that complements the production of solid phase resins, amino acid derivatives, peptides, and related products. The company was founded by Arno. F. Spatola in 1983 and is headquartered in Louisville, KY. | 8 anni |
| Chirag Bhavsar | M | 55 |
University of Florida
| 5 anni |
| Jason Greene | M | 54 |
University of Florida
| 5 anni |
| Mary R. Stouffer | F | - |
University of Florida
| 5 anni |
| Edwin C. Lunsford | M | 59 |
University of Florida
| 7 anni |
| Jack Mahler | M | - |
The University of North Carolina at Chapel Hill
| 8 anni |
| Walid Wael Ayoub Zurub | M | 57 |
University of Florida
| 5 anni |
| Robin L. Rains | F | - |
The University of North Carolina at Chapel Hill
| 6 anni |
| Gex Franklin Richardson | M | 59 |
University of Florida
| 6 anni |
| Mike Bain | M | - |
University of Florida
| 6 anni |
| Dan Rice | M | 61 |
University of Florida
| 5 anni |
| Jeffrey P. Brown | M | - |
The University of North Carolina at Chapel Hill
| 7 anni |
| Keith Jeffrey Blum | M | - |
University of Florida
| 5 anni |
| Joe Glorfield | M | - |
University of Florida
| 7 anni |
| Mehdi Hosseini | M | - |
University of Florida
| 5 anni |
| Louis Vincent Sicilian | M | - |
University of Florida
| 5 anni |
| David R. Carr | M | - |
The University of North Carolina at Chapel Hill
| 8 anni |
| Timothy A. Peterson | M | 58 |
University of Florida
| 6 anni |
| Ping Sung Wu | M | - |
University of Florida
| 5 anni |
| Kevin D. Cooper | M | - |
University of Florida
| 7 anni |
| Peter G. Kamay | M | - |
University of Florida
| 4 anni |
| Mark Rosman | M | - |
University of Florida
| 3 anni |
| Canon Coleman | M | 56 |
University of Florida
| 4 anni |
| David Webb | M | 64 |
University of Florida
| 3 anni |
| Wasim Wael Ayoub Zurub | M | 54 |
University of Florida
| 4 anni |
| Linda Bell | F | - |
University of Florida
| 4 anni |
| Scott Renner | M | 55 |
University of Florida
| 4 anni |
| Joseph C. Smallwood | M | 60 |
University of Florida
| 4 anni |
| Brad Ridinger | M | - |
University of Florida
| 4 anni |
| Lourdes Pitocchi | M | - |
University of Florida
| 3 anni |
| Angela P. Bryant | F | 58 |
University of Florida
| 3 anni |
| John P. Swaun | M | 55 |
University of Florida
| 4 anni |
| Harold Talisman | M | - |
University of Florida
| 4 anni |
| Russell S. Whittle | M | - |
University of Florida
| 1 anni |
| Paul Bassaline | M | - |
University of Florida
| 4 anni |
| Douglas Joel Vaughn | M | - |
University of Florida
| 4 anni |
| Geoffrey Allen Frazier | M | - |
University of Florida
| 4 anni |
| David B. Pfeil | M | - |
University of Florida
| 4 anni |
| Andrew Litvak | M | - |
University of Florida
| 3 anni |
| Alan G. Merten | M | 83 |
University of Florida
| 3 anni |
| Kay Lucas | F | - |
University of Florida
| 4 anni |
| Jillian Marcus | F | - |
University of Florida
| 4 anni |
| John F. Panzarella | M | - |
University of Florida
| 4 anni |
| Chin Tsun Lin | M | 63 |
University of Florida
| 1 anni |
| Bruce Rodgers | M | 60 |
University of Florida
| 3 anni |
| Brian Blakey | M | 61 |
University of Florida
| 4 anni |
| Jennifer Gu | M | 58 |
University of Florida
| 4 anni |
| Wells Hughes | M | - |
University of Florida
| 4 anni |
| Deborah Fasanelli | F | 58 |
University of Florida
| 4 anni |
| Keith Alexander | M | - |
University of Florida
| 4 anni |
| Liam O’Neil | M | - |
University of Florida
| 4 anni |
| Thomas Früh | M | 67 |
Bachem Bioscience, Inc.
| 2 anni |
| Douglas Marc Nelson | M | - |
University of Florida
| 4 anni |
| Gary A. Brooks | M | - |
University of Florida
| 4 anni |
| Gloria W. Fletcher | F | 72 |
University of Florida
| 3 anni |
| Meade Owens | F | - |
University of Florida
| 4 anni |
| Ken C. Murray | M | - |
University of Florida
| 4 anni |
| Peyvand M. Khademi | M | - |
University of Florida
| 4 anni |
| Peter Willis | M | 56 |
University of Florida
| 4 anni |
| Brian Shutts | M | - |
University of Florida
| 4 anni |
| Miguel A. Desdin | M | 58 |
University of Florida
| 4 anni |
| Stephen Sjuggerud | M | 52 |
University of Florida
| 4 anni |
| Daryl Hively | M | - |
University of Florida
| 4 anni |
| Shari Costantini | F | - |
University of Florida
| 4 anni |
| Cindy New | F | - |
University of Florida
| 4 anni |
| Wei Li Chen | M | - |
University of Florida
| 4 anni |
| Kenneth R. Bernstein | M | 57 |
University of Florida
| 4 anni |
| R. Bruce Christmas | M | - |
University of Florida
| 4 anni |
| Barry Michael Friedman | M | 58 |
University of Florida
| 4 anni |
| Samuel Wang | M | - |
University of Florida
| 4 anni |
| Sean Donovan Casterline | M | 55 |
University of Florida
| 4 anni |
| Kamil Engin Yesil | M | 62 |
University of Florida
| 4 anni |
| Hani Abdul Rahman Mustafa Al-Ali | M | 59 |
University of Florida
| 4 anni |
| Scott Museles | M | - |
University of Florida
| 4 anni |
| Alison Rand | F | 56 |
University of Florida
| 4 anni |
| John Salvaggio | M | 60 |
University of Florida
| 4 anni |
| Christopher L. Fetes | M | - |
University of Florida
| 4 anni |
| Dena M. Minning | M | - |
University of Florida
| 4 anni |
| Shamsul bin Saad | M | 60 |
University of Florida
| 4 anni |
| Mark Andrew Reed | M | 62 |
University of Florida
| 4 anni |
| Brad Hathorn | M | - |
University of Florida
| 3 anni |
| James R. Hagy | M | - |
University of Florida
| 5 anni |
| Michael Wayne Dahmer | M | - |
University of Florida
| 4 anni |
| Brad Donovan | M | - |
University of Florida
| 4 anni |
| DeEtte Feurtado | F | - |
University of Florida
| 4 anni |
| Elizabeth Patricia Gueits Martija | F | - |
University of Florida
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 93 | 93.00% |
| Isole Cayman | 10 | 10.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael William Pennington
- Contatti personali
